MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)

Lobbying for OSTEAL THERAPEUTICS, INC. · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $40,000.00 income · posted Jul 14, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

General federal government relations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.